Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content
Emboliste banner
Read the study
Discover how the EMBOLISE trial is shaping the future of treatment for subdural hematoma.
Review the key data

Watch Professor Jens Fiehler talking about the need for multi-disciplinary collaboration and how he envisages the CSDH patient pathway evolving.

Comprehensive access portfolio

Rist circle image

Rist™
 

Radial Access System

Avigo

Apollo™ & Marathon™ Onyx™

Delivery Microcatheters

Mirage circle image

MIRAGE™ 0.008"
 

Hydrophilic Guidewire

Phenom

Phenom™ Plus & Navien™ 58/72

Intermediate catheter

Echelon

Echelon™ 10/14
 

Microcatheters

Hyperform

HyperForm™ & HyperGlide™

Balloons

Medical education

Ask for information about our onsite workshop with
CSDH treatment experts here.
Learn more
Medical education surgeon circle

Therapy devices

The Onyx™ Confidence backed by over 20 years of data2, Onyx™ LES features predictable flow, ease of control, and exceptional cohesion and penetration, making it the liquid embolic to trust.
Learn more
Onyx bottles under blue light

Clinical data

EMBOLISE Trial

Multi-center, prospective, randomized, interventional, controlled, open label, adaptive design IDE trial

400

patients

39

centers

Magic MT

Multi-center, prospective, randomized, controlled trial
 

722

patients

31

centers

Are you an INR, Neurosurgeon or Hybrid Neurosurgeon

Medtronic facilitates conversations between the leading minds in this field. If you are interested in joining a roundtable discussion, meeting with one of the team above, or connecting with your peers, please complete this form and provide us with some more details. Connect with us.

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

1

Yang, W. and Huang, J., 2017. Chronic subdural hematoma: epidemiology and natural history. Neurosurgery Clinics, 28(2), pp.205-210

The material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).

Please note that the intended use of a product may vary depending on geographical approvals.

See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI. If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser.

For best results, use Adobe Acrobat® Reader with the browser. Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable). For any further information, contact your local Medtronic representative and/or consult Medtronic’s websites.